← All trials
NCT04601610
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2020
- Primary completion
- Apr 8, 2023
- Completion date
- Jun 15, 2023
- First posted
- Oct 26, 2020
- Last posted
- Oct 26, 2020
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alphamab Co., Ltd.Lead sponsor
- Sunshine Lake Pharma Co., Ltd.Collaborator
- People's Liberation Army of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.